Literature DB >> 31427447

Eosinophils Affect Antibody Isotype Switching and May Partially Contribute to Early Vaccine-Induced Immunity against Coxiella burnetii.

Lindsey Ledbetter1, Rama Cherla1, Catherine Chambers1, Yan Zhang1, Guoquan Zhang2.   

Abstract

Coxiella burnetii is an obligate intracellular Gram-negative bacterium which causes human Q fever. An acidified citrate cysteine medium (ACCM-2) has been developed which mimics the intracellular replicative niche of C. burnetii and allows axenic growth of the bacteria. To determine if C. burnetii cultured in ACCM-2 retains immunogenicity, we compared the protective efficacies of formalin-inactivated C. burnetii Nine Mile phase I (PIV) and phase II (PIIV) vaccines derived from axenic culture 7, 14, and 28 days postvaccination. PIV conferred significant protection against virulent C. burnetii as early as 7 days postvaccination, which suggests that ACCM-2-derived PIV retains immunogenicity and protectivity. We analyzed the cellular immune response in spleens from PIV- and PIIV-vaccinated mice by flow cytometry at 7 and 14 days postvaccination and found significantly more granulocytes in PIV-vaccinated mice than in PIIV-vaccinated mice. Interestingly, we found these infiltrating granulocytes to be SSChigh CD11b+ CD125+ Siglec-F+ (where SSChigh indicates a high side scatter phenotype) eosinophils. There was no change in the number of eosinophils in PIV-vaccinated CD4-deficient mice compared to the level in controls, which suggests that eosinophil accumulation is CD4+ T cell dependent. To evaluate the importance of eosinophils in PIV-mediated protection, we vaccinated and challenged eosinophil-deficient ΔdblGATA mice. ΔdblGATA mice had significantly worse disease than their wild-type counterparts when challenged 7 days postvaccination, while no significant difference was seen at 28 days postvaccination. Nevertheless, ΔdblGATA mice had elevated serum IgM with decreased IgG1 and IgG2a whether mice were challenged at 7 or 28 days postvaccination. These results suggest that eosinophils may play a role in early vaccine protection against C. burnetii and contribute to antibody isotype switching.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  ACCM-derived phase I vaccine; CD4+ T cells; Coxiella burnetii; antibody isotype switching; eosinophils; granulocytes

Mesh:

Substances:

Year:  2019        PMID: 31427447      PMCID: PMC6803328          DOI: 10.1128/IAI.00376-19

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  96 in total

Review 1.  The Q fever epidemic in The Netherlands: history, onset, response and reflection.

Authors:  H I J Roest; J J H C Tilburg; W van der Hoek; P Vellema; F G van Zijderveld; C H W Klaassen; D Raoult
Journal:  Epidemiol Infect       Date:  2010-10-05       Impact factor: 2.451

Review 2.  Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens.

Authors:  Joseph U Igietseme; Francis O Eko; Qing He; Carolyn M Black
Journal:  Expert Rev Vaccines       Date:  2004-02       Impact factor: 5.217

Review 3.  Components of protective immunity.

Authors:  Guoquan Zhang; Yan Zhang; James E Samuel
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

4.  Q-fever patients suffer from impaired health status long after the acute phase of the illness: results from a 24-month cohort study.

Authors:  Joris A F van Loenhout; Jeannine L A Hautvast; Jan H Vercoulen; Reinier P Akkermans; Clementine J Wijkmans; Koos van der Velden; W John Paget
Journal:  J Infect       Date:  2014-11-01       Impact factor: 6.072

Review 5.  Coxiella burnetii: turning hostility into a home.

Authors:  Jennifer H Moffatt; Patrice Newton; Hayley J Newton
Journal:  Cell Microbiol       Date:  2015-03-30       Impact factor: 3.715

Review 6.  Q fever and Coxiella burnetii: a model for host-parasite interactions.

Authors:  O G Baca; D Paretsky
Journal:  Microbiol Rev       Date:  1983-06

7.  Virus-induced eosinophil mediator release requires antigen-presenting and CD4+ T cells.

Authors:  Francis Davoine; Min Cao; Yingqi Wu; Farnam Ajamian; Ramses Ilarraza; Andy I Kokaji; Redwan Moqbel; Darryl J Adamko
Journal:  J Allergy Clin Immunol       Date:  2008-05-09       Impact factor: 10.793

8.  The role of IL-5 for mature B-1 cells in homeostatic proliferation, cell survival, and Ig production.

Authors:  Byoung-gon Moon; Satoshi Takaki; Kensuke Miyake; Kiyoshi Takatsu
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

9.  Distinct Effects of Monophosphoryl Lipid A, Oligodeoxynucleotide CpG, and Combination Adjuvants on Modulating Innate and Adaptive Immune Responses to Influenza Vaccination.

Authors:  Eun-Ju Ko; Young-Tae Lee; Youri Lee; Ki-Hye Kim; Sang-Moo Kang
Journal:  Immune Netw       Date:  2017-10-19       Impact factor: 6.303

10.  Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses.

Authors:  De Yang; Qian Chen; Shao Bo Su; Ping Zhang; Kahori Kurosaka; Rachel R Caspi; Suzanne M Michalek; Helene F Rosenberg; Ning Zhang; Joost J Oppenheim
Journal:  J Exp Med       Date:  2008-01-14       Impact factor: 14.307

View more
  2 in total

1.  Major Histocompatibility Complex Class II-Restricted, CD4+ T Cell-Dependent and -Independent Mechanisms Are Required for Vaccine-Induced Protective Immunity against Coxiella burnetii.

Authors:  Lindsey Ledbetter; Rama Cherla; Catherine Chambers; Yan Zhang; William J Mitchell; Guoquan Zhang
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

2.  Novel multiparameter correlates of Coxiella burnetii infection and vaccination identified by longitudinal deep immune profiling.

Authors:  P M Reeves; S Raju Paul; L Baeten; S E Korek; Y Yi; J Hess; D Sobell; A Scholzen; A Garritsen; A S De Groot; L Moise; T Brauns; R Bowen; A E Sluder; M C Poznansky
Journal:  Sci Rep       Date:  2020-08-07       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.